This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aprelikova, O. Articles by Barrett, J. C. Search for Related Content PubMed PubMed Citation Articles by Aprelikova, O. Articles by Barrett, J. C.

Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene Selection

Laboratory of Biosystems and Cancer, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Olga Aprelikova, National Cancer Institute, Building 37, Room 1044, 9000 Rockville Pike, Bethesda, MD 20892. Phone: 301-435-5774; Fax: 301-480-2772; E-mail: apreliko{at}mail.nih.gov.

Tumor hypoxia often directly correlates with aggressive phenotype, metastasis progression, and resistance to chemotherapy. Two transcription factors [hypoxia-inducible factor-1 (HIF-1) and HIF-2] are dramatically induced in hypoxic areas and regulate the expression of genes necessary for tumor adaptation to the conditions of low oxygen; however, the relative contribution of these factors is controversial. We used RNA interference–mediated inactivation of HIF-1 or HIF-2 followed by microarray analysis to identify genes specifically regulated by either HIF-1 or HIF-2 in hypoxia. We found that, in the MCF7 cell line, the vast majority of hypoxia-responsive genes (>80%) were dependent on the presence of HIF-1. However, a small group of genes were preferentially regulated by HIF-2. Promoter analysis for this group of genes revealed that all of them have putative binding sites for ETS family transcription factors, and 10 of 11 HIF-2-dependent genes had at least one potential hypoxia-responsive element (HRE) in proximity to an ETS transcription factor binding site. Knockdown of ELK-1, the most often represented member of ETS family, significantly reduced hypoxic induction of the HIF-2-dependent genes. Physical and functional interaction between ELK-1 and HIF-2 were supported by coimmunoprecipitation of these two proteins, luciferase reporter assay using CITED2 promoter, and binding of ELK-1 protein to the promoters of CITED2 and WISP2 genes in proximity to a HRE. These data suggest that the choice of the target genes by HIF-1 or HIF-2 depends on availability and cooperation of HIFs with other factors recognizing their cognate elements in the promoters. (Cancer Res 2006; 66(11): 5641-7)

This article has been cited by other articles:

				O. I. Ndubuizu, J. C. Chavez, and J. C. LaManna Increased prolyl 4-hydroxylase expression and differential regulation of hypoxia-inducible factors in the aged rat brain Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R158 - R165. [Abstract] [Full Text] [PDF]

				A. Ahmad, S. Ahmad, L. Glover, S. M. Miller, J. M. Shannon, X. Guo, W. A. Franklin, J. P. Bridges, J. B. Schaack, S. P. Colgan, et al. Adenosine A2A receptor is a unique angiogenic target of HIF-2{alpha} in pulmonary endothelial cells PNAS, June 30, 2009; 106(26): 10684 - 10689. [Abstract] [Full Text] [PDF]

				O. Aprelikova, S. Pandolfi, S. Tackett, M. Ferreira, K. Salnikow, Y. Ward, J. I. Risinger, J. C. Barrett, and J. Niederhuber Melanoma Antigen-11 Inhibits the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 and Activates Hypoxic Response Cancer Res., January 15, 2009; 69(2): 616 - 624. [Abstract] [Full Text] [PDF]

				K. Helczynska, A.-M. Larsson, L. Holmquist Mengelbier, E. Bridges, E. Fredlund, S. Borgquist, G. Landberg, S. Pahlman, and K. Jirstrom Hypoxia-Inducible Factor-2{alpha} Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer Cancer Res., November 15, 2008; 68(22): 9212 - 9220. [Abstract] [Full Text] [PDF]

				D. Dutta, S. Ray, J. L. Vivian, and S. Paul Activation of the VEGFR1 Chromatin Domain: AN ANGIOGENIC SIGNAL-ETS1/HIF-2{alpha} REGULATORY AXIS J. Biol. Chem., September 12, 2008; 283(37): 25404 - 25413. [Abstract] [Full Text] [PDF]

				K. Salnikow, O. Aprelikova, S. Ivanov, S. Tackett, M. Kaczmarek, A. Karaczyn, H. Yee, K. S. Kasprzak, and J. Niederhuber Regulation of hypoxia-inducible genes by ETS1 transcription factor Carcinogenesis, August 1, 2008; 29(8): 1493 - 1499. [Abstract] [Full Text] [PDF]

				H.-M. Zhang, L. Li, N. Papadopoulou, G. Hodgson, E. Evans, M. Galbraith, M. Dear, S. Vougier, J. Saxton, and P. E. Shaw Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1 Nucleic Acids Res., May 1, 2008; 36(8): 2594 - 2607. [Abstract] [Full Text] [PDF]

				G. Song, J. Kim, F. W. Bazer, and T. E. Spencer Progesterone and Interferon Tau Regulate Hypoxia-Inducible Factors in the Endometrium of the Ovine Uterus Endocrinology, April 1, 2008; 149(4): 1926 - 1934. [Abstract] [Full Text] [PDF]

				C.-J. Hu, A. Sataur, L. Wang, H. Chen, and M. C. Simon The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1{alpha} and HIF-2{alpha} Mol. Biol. Cell, November 1, 2007; 18(11): 4528 - 4542. [Abstract] [Full Text] [PDF]

				R. D. Guzy and P. T. Schumacker Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia Exp Physiol, September 1, 2006; 91(5): 807 - 819. [Abstract] [Full Text] [PDF]